Condition: Schizophrenia · Negative Symptoms in Schizophrenia · Depressive Symptoms Due to Primary Psychotic Disorder (Diagnosis) · Sponsor: Lithuanian University of Health Sciences
This study aims to validate the Lithuanian version of the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale in a Lithuanian sample. This will be done by comparing results obtained from the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale with results obtained from the Positive and Negative Symptoms Scale, the Montgomery Asberg Depression Rating Scale, and the Montreal Cognitive Assessment test.
This description comes directly from the study's public registry record.
Jonas Montvidas, MD · +37066240919 · jonas.montvidas@lsmu.lt
Algirdas Musneckis, MD · +37061378748 · algirdas.musneckis@kaunoklinikos.lt
Always discuss trial participation with your own doctor first.
| Lithuanian University of Health Sciences Hospital Kaunas Clinics | Kaunas, Lithuania | Recruiting |
| Jonas Montvidas | Kaunas, Lithuania | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06278532